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Plasmacytoid dendritic cells (pDCs) mediate type I
interferon (IFN-I) responses to viruses that are recog-
nized through the Toll-like receptor 7 (TLR7) or TLR9
signaling pathway. However, it is unclear how pDCs
regulate the antiviral responses via innate and adap-
tive immune cells. We generated diphtheria toxin
receptor transgenic mice to selectively deplete
pDCs by administration of diphtheria toxin. pDC-
depleted mice were challenged with viruses known
to activate pDCs. In murine cytomegalovirus
(MCMV) infection, pDC depletion reduced early
IFN-I production and augmented viral burden facili-
tating the expansion of natural killer (NK) cells ex-
pressing the MCMV-specific receptor Ly49H. During
vesicular stomatitis virus (VSV) infection, pDC deple-
tion enhanced early viral replication and impaired the
survival and accumulation of virus-specific cytotoxic
T lymphocytes. We conclude that pDCs mediate
early antiviral IFN-I responses and influence the
accrual of virus-specific NK or CD8+ T cells in a
virus-dependent manner.
INTRODUCTION
Plasmacytoid dendritic cells (pDCs) are bone marrow-derived
leukocytes that secrete large amounts of type I interferons
(IFN-I), i.e., IFN-a and -b, in response to a variety of viruses
in vitro and in vivo (Gilliet et al., 2008). IFN-I confer resistance
to viral infections and promote apoptosis of virally infected cells
(Garcı´a-Sastre and Biron, 2006; Honda et al., 2005c; Pestka
et al., 2004). Moreover, IFN-I promote natural killer (NK) cell,
dendritic cell (DC), T cell, and B cell functions (Banchereau and
Pascual, 2006; Garcı´a-Sastre and Biron, 2006; Kolumam et al.,
2005; Le Bon and Tough, 2008). Thus, pDCs have been impli-
cated in the control of both innate and adaptive host antiviral
responses.
Besides producing IFN-I, pDCs may contribute to antiviral
defense through additional mechanisms. pDCs express major
histocompatibility complex (MHC) molecules and costimulatory
molecules, and therefore may directly present viral antigens toICD4+ T cells and cross-present viral antigens to CD8+ T cells (Vil-
ladangos and Young, 2008). In addition, pDCs are a source of
proinflammatory chemokines, including CCL3, CCL4, CCL5,
CXCL9, and CXCL10, which can attract activated CD4+ and
CD8+ T cells to sites of infection (Sozzani et al., 2010). pDCs
also secrete interleukin-12 (IL-12), contributing to T helper 1
(Th1) cell polarization of CD4+ T cells (Asselin-Paturel et al.,
2001; Cella et al., 2000). Additionally, pDCs can directly kill
virus-infected cells through FasL- and tumor necrosis factor-
related apoptosis inducing ligand (TRAIL)-dependent mecha-
nisms (Chaperot et al., 2006; Hardy et al., 2007).
pDCs detect RNA and DNA viruses through two endosomal
sensors, Toll-like receptors (TLR) 7 and TLR9, which induce
secretion of IFN-I through theMyD88-interferon regulatory factor
7 (IRF7) signaling pathway (Blasius and Beutler, 2010; Honda
et al., 2005a; Pichlmair and Reis e Sousa, 2007; Takeuchi and
Akira, 2009; Thompson and Iwasaki, 2008). Viruses reach
TLR7 and TLR9 via receptor-mediated endocytosis or transport
of cytosolic replication intermediates into endosomes by au-
tophagy (Thompson and Iwasaki, 2008; Wang et al., 2007).
Various DNA and RNA viruses activate pDCs (Borrow and
Bhardwaj, 2008; Cervantes-Barragan et al., 2007; Delale et al.,
2005; Diebold et al., 2004; Jung et al., 2008; Krug et al., 2004a,
2004b; Steinberg et al., 2009; Thompson and Iwasaki, 2008;
Yoneyama et al., 2005; Zucchini et al., 2008) without the need
for viral replication (Kumagai et al., 2009). Moreover, TLR7-,
TLR9-, MyD88-, and IRF7-deficient mice fail to secrete sufficient
IFN-I after certain viral infections, resulting in increased viral
replication and mortality in comparison to wild-type mice (Delale
et al., 2005; Honda et al., 2005b; Steinberg et al., 2009; Thomp-
son and Iwasaki, 2008; Zucchini et al., 2008). However, it is not
clear whether pDCs are primarily responsible for TLR7- or
TLR9-MyD88-IRF7-mediated antiviral responses in vivo. More-
over, whether pDCs impact the control of viral infection via
mechanisms other than IFN-I in vivo is poorly understood.
One approach to assessing pDC functions in vivo is to analyze
antiviral host responses in mice lacking pDCs. To this end, pDCs
have been depleted by the administration of monoclonal anti-
bodies specific for pDC surface antigens such as Gr-1 (Asse-
lin-Paturel et al., 2001) or bone marrow stromal antigen 2
(BST-2) (Asselin-Paturel et al., 2003; Blasius et al., 2006b; Krug
et al., 2004a). Although informative, one limitation of antibody
(Ab) depletion studies is that the Gr-1 antigen (Ag) is expressed
by pDCs, plasma cells (Wrammert et al., 2002), inflammatory
monocytes (Barbalat et al., 2009), subsets of T cells (Walunasmmunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc. 955
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expressed on pDCs and plasma cells in naive mice but is
induced on most cell types after stimulation with IFN-I or IFN-g
(Blasius et al., 2006b). Therefore, pDC-depleting Abs can
deplete additional cell types during viral infection and the subse-
quent immune response, thus confounding the interpretation of
these studies.
An alternative approach to Ab depletion is to evaluate mutant
mice that are deficient for pDCs, specifically mice lacking
the transcription factor E2-2 (Cisse et al., 2008) or with a hypo-
morphic mutation of Ikaros (Ikzf1L/L) (Allman et al., 2006).
Because Ikaros is also expressed in non-pDC subsets and
pDCs are not completely eliminated in Ikzf1L/L mice (Allman
et al., 2006), this mouse model presents similar limitations as
pDC-depleting antibodies. E2-2-deficient mice have a more
specific pDC defect, but have not yet been evaluated for suscep-
tibility to viral infections.
To precisely address the impact of pDCs in innate and
adaptive antiviral immune responses, we generated transgenic
(Tg) mice that express the diphtheria toxin receptor (DTR) under
the control of the highly specific human pDC gene promoter,
BDCA-2. Administration of diphtheria toxin (DT) to these mice
resulted in an almost complete and selective depletion of
pDCs. pDC-depleted mice were challenged with representative
DNA and RNA viruses, murine cytomegalovirus (MCMV), and
vesicular stomatitis virus (VSV), respectively. Our results demon-
strated that pDCs provide an immediate but limited source of
IFN-I that restricts viral burden only in the very early phase of
infection. Lack of pDC-mediated containment of MCMV resulted
in the increased expansion of NK cells expressing the Ly49H
receptor. In contrast, during VSV infection, pDC depletion
reduced the amplitude of primary CD8+ T cell responses result-
ing from impaired survival of virus-specific cytotoxic T cells
(CTLs). Thus, pDCs impact virus-specific NK cell or CD8+
T cell responses in a fashion that is dependent on the infecting
agent.
RESULTS
Specific pDC Depletion in BDCA2-DTR Transgenic Mice
Evaluating the role of DCs in orchestrating immune responses
has been greatly facilitated by the generation of Tg mice that
express DTR under the control of the DC-specific CD11c
promoter (Jung et al., 2002). Administration of DT to CD11c-
DTR Tg mice selectively eliminates CD11chi classical DCs.
Emulating this approach, we generated Tg mice that express
DTR under the blood dendritic cell antigen 2 (BDCA-2) promoter.
BDCA-2 is a C-type lectin that is exclusively expressed by
human pDCs (Gilliet et al., 2008). Although BDCA-2 is not en-
coded in mouse, we assumed that its promoter contains target
sequences for pDC-specific transcription factors that might be
conserved across species. Indeed, this assumption was correct;
the transcription factor E2-2, which is a specific regulator of pDC
development in mouse and human, was subsequently shown to
interact with elements in the BDCA-2 promoter (Cisse et al.,
2008). Therefore, we generated a BDCA2-DTR Tg mouse on a
C57BL/6 background in which pDCs were systemically depleted
with high efficiency and specificity 24 hr after DT administration
(Figure 1). The DT-induced depletion persisted for 2 to 3 days;956 Immunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc.however, pDCs could be depleted for longer periods with
repeated DT administration. The depletion efficiency in blood,
spleen, liver, and lymph nodes was approximately 90%
24–48 hr after DT treatment (data not shown). To further demon-
strate that DT specifically depletes pDCs, BDCA2-DTR Tg mice
were bred to SiglecH-eGFP (enhanced green fluorescent
protein) gene-targeted mice (Figure S1A available online). In
these mice, pDCs expressed high amounts of eGFP, whereas
classical DCs expressed low amounts of eGFP (Figure S1B).
DT administration to BDCA2-DTR Tg 3 SiglecH-eGFP gene-
targeted mice resulted in the selective depletion of pDCs
whereas classical DCs were left intact (Figure S1C). Thus, the
BDCA2-DTR Tgmouse is a unique tool to specifically investigate
the function of pDCs in a variety of models.
pDCs Limit MCMV Replication Independently
of Ly49H+ NK Cells
NK cells play a critical role in controlling MCMV infection by
killing infected cells in the spleen and producing IFN-g in the
liver (Biron et al., 1999). In C57BL/6 mice, NK cells recognize
MCMV-infected cells when the MCMV-encoded m157 protein
expressed on the surface of infected cells binds to the Ly49H
activating receptor on a subset of NK cells (Lanier, 2008). NK
cells are also activated by IFN-I and other cytokines (Biron
et al., 1999; Garcı´a-Sastre and Biron, 2006), which are released
by MCMV-activated pDCs. Thus, it has been thought that pDCs
may contribute to anti-MCMV defense primarily by activating NK
cell-mediated surveillance.
To address the role of pDCs in controlling viral burden, we
infected control and DT-treated mice with different doses of
MCMV intraperitoneally (i.p.) and examined viral titers in multiple
tissues. In control mice, MCMV systemically activated pDCs
in vivo, as assessed by expression of the activation marker
PDC-TREM (Figure S2A; Watarai et al., 2008). In DT-treated
mice, pDCs were effectively depleted in spleen and liver without
having major effects on the total numbers of cells (Figure S2B–
S2D). Furthermore, we confirmed that DT treatment did not
eliminate cells critical for antiviral responses such as virus-
specific NK cells and CD8+ T cells during MCMV infection
(Figures S2E and S2F). On day 3 postinfection (p.i.), viral titers
in the spleen were significantly higher in DT-treated mice when
a dose of 5 3 104 plaque-forming units (pfu) per mouse was
administered whereas no differences were observed at a higher
(1 3 105 pfu) dose (Figure 2A). When we quantified viral titers in
the livers on day 3 p.i., we found that pDC-depleted mice had
significantly higher viral titers than control mice only at a low
dose (1 3 104 pfu) (Figure 2B).
Because MCMV has tropism for the salivary glands and repli-
cates there during the later stages of infection (Krmpotic et al.,
2003), we next evaluated salivary gland viral titers in control
and pDC-depleted mice on day 8 p.i. In these experiments,
wild-type (WT) MCMV (5 3 104 pfu) as well as MCMV lacking
m157 (Dm157 MCMV) (1 3 104 pfu) were used to infect mice.
Our rationale for using Dm157 MCMV is that this virus escapes
surveillance by Ly49H+ NK cells in C57BL/6 mice (Lanier,
2008), allowing the evaluation of pDC impact on viral control
independently of Ly49H+ NK cells. Salivary glands from pDC-
depleted mice infected with either WT or Dm157 MCMV had
significantly elevated viral loads (Figure 2C). We also examined
Figure 1. Generation of BDCA2-DTR Tg Mice and Selective
Depletion of pDCs
(A) The construct for BDCA2-DTR Tg mice includes a 5 kb fragment upstream
of the ATG of the BDCA-2 gene, a cDNA fragment encoding DTR, and the
human growth hormone (hGH) gene polyadenylation signal.
(B and C) DT administration specifically depletes pDCs in BDCA2-DTR Tg
mice. Cell subsets in spleen (B) and blood (C) were analyzed by flow cytometry
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Ithe salivary glands from control and pDC-depletedmice infected
with 1 3 105 pfu of WT MCMV for 8 days and found no differ-
ences in viral titers (data not shown). These results demonstrate
that at lower doses of MCMV, the presence of pDCs can limit
viral burden in the spleen, liver, and salivary glands. However,
at higher inoculi of MCMV, pDCs are not sufficient to control viral
loads. The results obtained with Dm157 MCMV infection also
indicate that pDCs can control MCMV infection independently
of Ly49H+ NK cells.
pDC Depletion Has Distinct Effects on Nonspecific
and Specific NK Cell Activation
It has been established that NK cell surveillance of MCMV infec-
tion develops through distinct phases (Dokun et al., 2001). In the
early phase of infection, NK cell activation and secretion of IFN-g
is independent of Ly49H engagement but depends on cytokines.
During the later phase of infection, Ly49H+ NK cells are selec-
tively activated and proliferate in response to MCMV. After viral
clearance, Ly49H+ NK cells undergo contraction and generate
a population of memory cells (Sun et al., 2009). To assess the
effect of pDCs on NK cell activity in the early phase of infection,
we infected pDC-depleted and control mice with MCMV and
measured spleen NK cell frequencies, activation, ability to kill
target cells, and intracellular IFN-g content. The overall frequen-
cies of NK cells in the spleen declined over time in both groups of
mice (Figure 3A). At 36 hr p.i., NK cells from pDC-depleted mice
had reduced expression of CD69 compared to control mice
whereas mice from both groups at 48 hr p.i. expressed similar
amounts of CD69 (Figure 3B). At 24 hr p.i., NK cells from pDC-
depleted mice were less efficient at killing RMA-S target cells
(Figure 3C). At 36 and 48 hr, this difference in specific lysis
was no longer observed between control and pDC-depleted
mice. Thus, in the absence of pDCs, activation and cytotoxicity
of nonspecific NK cells is impaired very early on during infection.
The effect of pDC depletion on NK cell secretion of IFN-g was
opposite. Frequencies of IFN-g-producing NK cells were similar
in control and pDC-depleted mice at 24 and 36 hr p.i. At 48 hr,
IFN-g-producing NK cells declined in both groups of mice;
however, therewere significantly more IFN-g-producing NK cells
(2.5-fold) in pDC-depleted mice (Figure 3D). Additionally, we
observed increased frequencies of IFN-g-producing NKT cells
in the spleens and livers of pDC-depleted mice compared to
controls (Figure S3). Thus, in the absence of pDCs, IFN-g secre-
tion by NK cells and NKT cells is facilitated.
To assess the effect of pDCs on the MCMV-specific NK cell
response, we infected pDC-depleted and control mice with
MCMV and measured frequencies of Ly49H+ and Ly49H NK
cells and their intracellular IFN-g content 3 days p.i. pDC-
depletedmice showed increased frequencies of Ly49H+NK cells
as well as more IFN-g-producing Ly49H+ NK cells than control
mice (Figure 3E). These results prompted us to examine
NK1.1+ and Ly49H+ NK cell numbers at different time points
p.i. As anticipated, pDC-depleted mice had a greater accumula-
tion of total NK1.1+ and Ly49H+ NK cells during the later phase of
infection (Figure 3F). Taken together, these results demonstrate24 hr after DT injection. Data shown are representative of at least three
experiments. Classical DCs (cDC), macrophages (Mac), resident (R), inflam-
matory (I), monocytes (Mono), and granulocytes (PMN).
mmunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc. 957
Figure 2. pDC-Mediated Inhibition of MCMV Replication Is Depen-
dent on Viral Inoculum
(A and B) PBS- or DT-treated mice were infected i.p. with different doses of
MCMV and viral titers in spleen (A) and liver (B) were enumerated on day 3
p.i. by plaque assay.
(C) PBS- or DT-treated mice were infected i.p. with MCMV or Dm157 MCMV
and salivary gland (SG) viral titers were calculated on day 8 p.i.
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958 Immunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc.that pDCs promote transient NK cell activation and cytotoxicity
in the early phase of MCMV infection, but limit NK cell and
NKT cell secretion of IFN-g. At later time points, pDC depletion
does not affect the selective expansion and function of Ly49H+
NK cells, which are in fact more abundant, most probably as a
response to increased viral replication and subsequent engage-
ment of Ly49H by m157.
pDCs Are a Transient Source of IFN-I that Modulates
IL-12 and IFN-g Production
To investigate themechanisms by which pDCs control low-inter-
mediate inoculi of MCMV, induce activation of NK cells, and
modulate NK cell and NKT cell secretion of IFN-g, we examined
serum cytokine concentrations in pDC-depleted mice at
different time points. pDC-depleted mice produced significantly
less IFN-a at 36 hr p.i. whereas no differences in serum IFN-a
were observed at 48 hr (Figure 4A). Thus, pDCs are the major
source of IFN-I during the initial stages of MCMV infection
whereas non-pDCs are responsible for the IFN-I produced at
later time points (Asselin-Paturel et al., 2001; Dalod et al.,
2002, 2003; Delale et al., 2005; Scheu et al., 2008). In addition,
pDC-depleted mice had 3- to 4-fold more serum IFN-g than
nondepleted mice 48 hr p.i. (Figure 4B), reflecting the increased
IFN-g production by NK cells and NKT cells. The impact of pDC
depletion on IFN-g serum concentrations was dependent on the
viral inoculum. DT-treated mice infected with low or intermediate
doses of WT MCMV had higher concentrations of serum IFN-g
compared to control mice (Figure 4C). DT-treated mice infected
with Dm157 MCMV also had elevated amounts of serum IFN-g.
In contrast, no differences were apparent when DT-treated mice
were infected with 13 105 pfu of WT virus. These results corrob-
orate that the role of pDCs in early cytokine responses to MCMV
infection is prominent only at low viral inoculi.
The increase of serum IFN-g in pDC-depleted mice was
mirrored by a parallel increase of serum IL-12 (Figure 4D), which
probably triggered IFN-g production. It was previously shown
that CD11b+ DCs from MCMV-infected mice depleted of pDCs
with anti-Gr-1 produce more IL-12 (Dalod et al., 2002). Consis-
tent with these results, we found more IL-12-producing CD11chi
cells in DT-treated mice than in the control group (Figure 4E).
Most probably this reflects an inhibitory effect of the IFN-a
released by pDCs on IL-12 secretion by classical DCs (Dalod
et al., 2002, 2003). Taken together, these results demonstrate
that pDCs provide a transient source of IFN-I that limits the
IL-12-IFN-g axis in response to low viral inoculi.
Impact of pDCs on DC Activation and Early
MCMV-Specific CD8+ T Cell Responses
We observed that CD11chi DCs from MCMV-infected pDC-
depleted mice expressed lower amounts of MHC class II at 24
and 36 hr p.i. and CD86 at 36 hr p.i.; however, these differences
ceased at 48 hr (Figure 4F). pDC depletion had little effect on
CD40 or CD80 expression by CD11chi DCs. Thus, the absence
of pDCs affects the activation of DCs during the initial phase of
MCMV infection. However, this transient delay of DC activation
was insufficient to affect subsequent CD8+ T cell responses inp value, unpaired, two-tailed Student’s t test. Data shown are from two
experiments.
Figure 3. pDC Impact on Nonspecific and
Specific NK Cell Activation during MCMV
Infection
Mice were infected i.p. with MCMV (5 3 104 pfu).
(A) Frequencies of NK cells (NK1.1+CD3) in
spleens.
(B) Expression of CD69 on splenic NK cells.
(C) Cytotoxic capacity of splenic NK cells from
control and pDC-depleted mice with RMA-S
target cells in standard 4 hr 51Cr release assays.
(D) Frequencies of IFN-g+ NK cells in spleens of
MCMV-infected mice.
(E) Frequencies of Ly49H+ and IFN-g+-producing
NK cells on day 3 p.i. Data are representative of
six to eight mice from two experiments.
(F) Total numbers of NK1.1+ and Ly49H+NK1.1+
cells during MCMV infection.
(B and D) p value, unpaired, two-tailed Student’s
t test.
(C and F) Asterisks denote p values % 0.03 as
measured by unpaired, two-tailed Student’s t test.
(A–D, F) Data are from two experiments (mean ±
SEM, n = 5–7).
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(Figure 4G).
pDCs Mediate Early IFN-I Responses during VSV
Infection
To obtain a broader view of pDC function in viral infections, we
assessed the contribution of pDCs in an infectionmodel by using
anRNAvirus. Because the TLR7-MyD88-IRF7 pathway has been
shown to be important for the control of VSV infection and for
pDC responses to VSV (Honda et al., 2005b; Thompson and Iwa-
saki, 2008), we evaluated the role of pDCs during an infection
with recombinant VSV expressing ovalbumin (VSV-OVA). To
this end, control and pDC-depleted mice were infected intrave-
nously (i.v.) with VSV-OVA. In control mice, B220+Siglec-H+
spleen pDCs were activated and expressed PDC-TREM as early
as 6 hr p.i. PDC-TREM could also be detected on pDCs in theImmunity 33, 955–966, Dblood, bone marrow, and liver 24 hr p.i.
(Figure S4). We also measured serum
IFN-a concentrations and virus titers in
the spleen at different time points p.i. In
the absence of pDCs, IFN-awas reduced
at 6 hr p.i. but not at 12or 24hr (Figure 5A).
We also found a significant difference
in viral loads between control and pDC-
depleted mice at 6 hr p.i., whereas it
was difficult to detect VSV-OVA in the
periphery after 24 hr (Figure 5B and data
not shown). Thus, pDCs contribute to
IFN-I production and control viral burden
very early during VSV-OVA infection.
pDCs Influence Anti-VSV CD8+
T Cell Responses In Vivo
Next we analyzed spleens from VSV-
OVA-infected mice on day 7 p.i. Spleens
from pDC-depleted mice containedfewer cells and were slightly smaller than controls (Figure 5C
and data not shown). Closer examination with H-2Kb OVA257-264
peptide tetramers revealed reduced frequencies and numbers of
Ag-specific CD8+ T cells in pDC-depleted mice (Figure 5D). We
also noted a reduction in the frequencies and numbers of
Ag-specific CD8+ T cells from pDC-depletedmice that produced
IFN-g after stimulation with PMA+Ionomycin or OVA257-264
(SIINFEKL) peptide (Figure 5E). To test whether Ag-specific
CD8+ T cells from both groups of mice were capable of killing
target cells, we incubated splenocytes with either untreated or
SIINFEKL-pulsed EL4 cells in standard chromium release
assays. In accordance with the reduced frequencies of tetramer+
and IFN-g+ cells in pDC-depleted mice, less specific lysis was
observed compared to controls (Figure 5F). These data show
that pDCs are important for the establishment of viral-specific
CD8+ T cell responses in this model of viral infection.ecember 22, 2010 ª2010 Elsevier Inc. 959
Figure 4. Impact of pDCs on Cytokine
Production, DC Activation, and Early Anti-
MCMV CD8+ T Cell Responses
(A, B, D–G) PBS- and DT-treated mice were in-
fected i.p. with 5 3 104 pfu of MCMV and serum
samples were analyzed for IFN-a (A), IFN-g (B),
and IL-12p70 (D).
(C) PBS- and DT-treated mice were infected i.p.
with different doses of WT MCMV or Dm157
MCMV and serum IFN-g concentrations were
quantified 48 hr p.i.
(E) Frequencies of IL-12+CD11chi cells were deter-
mined 48 hr p.i. by intracellular staining.
(F) Expression based on mean fluorescence inten-
sity (MFI) of costimulatory (CD86, CD40, CD80)
and MHC class II molecules on CD11chi DCs.
(G) Frequencies and absolute numbers of Ag-
specific CD8+ T cells on day 6 p.i.
p value, unpaired, two-tailed Student’s t test. Data
are from two (A, B, D–G) or three (C) experiments
(mean ± SEM, n = 5–25).
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T Cells during VSV Infection
To corroborate that pDCs indeed facilitate the accumulation of
Ag-specific CD8+ T cells during VSV infection, we set up an
adoptive transfer system in which CD8+ T cells from OT-I TCR
Tg mice were labeled with the cytoplasmic dye CFSE and
injected into BDCA2-DTR Tg mice. The following day, mice
were administered either phosphate-buffered saline (PBS) or
DT and then infected with VSV-OVA. When spleens were
examined 66 hr p.i., we found that the transferred CD8+ T cells
in both groups of mice were proliferating based on CFSE
dilutions (Figure 6A); however, the frequencies as well as the
absolute numbers of CD8+Va2+CFSE+ cells were 3-fold higher
in nondepleted mice (Figure 6B) (Va2 is the T cell receptor
[TCR] a chain used by OT-I OVA-specific CD8+ T cells). Taken
together, these data demonstrate that pDCs enhance the accu-
mulation of Ag-specific CD8+ T cells during VSV infection.
pDCs Promote the Survival of VSV-Specific CD8+ T Cells
We next asked how pDCs contribute to the accumulation of
Ag-specific CD8+ T cells. pDCs may elicit the expansion of960 Immunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc.CD8+ T cells by activating bystander
DCs (Yoneyama et al., 2005). Therefore,
we examined DC numbers, activation
state, and Ag presentation in control
and pDC-depleted VSV-OVA-infected
mice, but found no differences in DC
numbers (Figure S5A) or the upregulation
of costimulatory or MHC class II mole-
cules on CD11chi DCs (data not shown).
We also observed no differences in the
ability of CD11c+ DCs enriched from
VSV-OVA-infected control or pDC-
depleted mice to present Ag to CD8+ T
or CD4+ T cells purified from OT-I or
OT-II TCR Tg mice, respectively (Fig-
ure S5B). We also sorted DC subsets
from VSV-OVA-infected control andpDC-depleted mice and found (1) that CD8a+ DCs and CD8a
DCs from both groups of mice were equally capable of present-
ing Ag to OT-I andOT-II cells and (2) that pDCs do not present Ag
to OT-I or OT-II cells (data not shown).
pDCs preferentially secrete chemokines such as CCL3 and
CCL4 (Sozzani et al., 2010), which have been shown to recruit
naive CD8+ T cells into priming sites. Thus, depleting pDCs
may affect the recruitment of naive CD8+ T cells to the spleens
of VSV-OVA-infected mice. Quantification of these two chemo-
kines in the serum of VSV-OVA-infected mice revealed that
both groups of mice produced CCL3 and CCL4 (data not shown
and Figure 7A); however, there was a significant reduction in
serum CCL4 in pDC-depleted mice 24 hr p.i. To assess whether
the reduction in CCL4 affected the recruitment of Ag-specific
CD8+ T cells, we examined the frequencies of adoptively trans-
ferred OT-I cells in spleens at early time points p.i. in control
and pDC-depleted mice and compared them to that of naive
mice. At 6 hr p.i., the frequencies of OT-I cells in control and
pDC-depleted mice were comparable to uninfected mice, indi-
cating that recruitment of Ag-specific CD8+ T cells was not
impaired. At 22 hr p.i., the frequencies of OT-I began to decline
Figure 5. pDCs Augment Ag-Specific CD8+ T Cell Responses during
VSV-OVA Infection
PBS- or DT-treated mice were infected i.v. with 53 106 pfu (A, C–F) or 53 105
pfu (B) of VSV-OVA.
(A) IFN-a concentrations in serum were determined at 6, 12, or 24 hr p.i.
(B) Viral titers in spleens were measured at 6 hr p.i.
(C–F) Spleens from VSV-OVA-infected mice were analyzed on day 7 p.i.
(C) Spleen cellularity.
(D) Spleen cells from infected mice were stained with H-2Kb OVA257-264
peptide tetramers and anti-CD8. Frequencies and total numbers of Ag-specific
CD8+ T cells were determined by flow cytometry.
(E) Frequencies and numbers of CD8+ T cells producing IFN-g after restimula-
tion with SIINFEKL were determined by flow cytometry.
(A–E) p value, unpaired, two-tailed Student’s t test. Data are from two to five
experiments (mean ± SEM, n = 6–19).
(F) Antigen-specific cytotoxicity was assessed in standard 4 hr 51Cr release
assays. Asterisks denote p values% 0.03 asmeasured by unpaired, two-tailed
Student’s t test. Data are from two experiments (mean ± SEM, n = 6–7).
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compared to PBS controls (Figure 7B), suggesting that pDCs
may impact the survival of Ag-specific CD8+ T cells.ITo address whether the initial decline in OT-I frequencies was
due to Ag-induced apoptosis, we infected mice in the footpads
with VSV-OVA or VSV and compared the frequencies of OT-I
cells in the contralateral lymph nodes (CLN) to those in the drain-
ing lymph nodes (DLN) (Figure 7C). At 9 hr p.i., the frequencies of
OT-I begin to decline in the DLN of VSV-OVA-infected mice but
not in the DLN of VSV-infectedmice. At 25 hr p.i., the reduction in
frequencies was evenmore dramatic in VSV-OVA-infectedmice,
suggesting that OT-I cells do in fact undergo Ag-induced
apoptosis. To corroborate this finding, we evaluated the
apoptosis of adoptively transferred OT-I cells in spleens of
control or pDC-depleted mice infected i.v. with VSV-OVA by
using Annexin V and CaspACE FITC-VAD-FMK (which binds to
activated caspase). As anticipated, more apoptotic Ag-specific
CD8+ T cells were evident in pDC-depleted mice, especially at
66 hr p.i. (Figure 7D). Taken together, these results demonstrate
that pDCs promote the survival of Ag-specific CD8+ T cells
during VSV-OVA infection.DISCUSSION
In this study, we have addressed the contribution of pDCs to
antiviral responses by using a BDCA2-DTR Tg mouse that we
have generated in our lab. We first showed that pDCs can be
almost entirely and specifically depleted in thesemice, providing
an optimal experimental system to evaluate pDC functions
in vivo. This experimental model appears to be superior to
depleting antibodies, because the available antibodies also
recognize non-pDCs, potentially depleting other cells involved
in immune responses. Cross-reactivity is particularly problem-
atic when BST-2 antibodies are used during viral infections,
because BST-2 is upregulated on a wide variety of cells in
response to IFNs (Blasius et al., 2006b), resulting in their deple-
tion. Although Siglec-H is predominately expressed on pDCs
(Blasius et al., 2006a; Zhang et al., 2006), SiglecH-eGFP gene-
targeted mice exhibited eGFP expression not only in pDCs but
also in classical DCs, suggesting that the promoter of BDCA-2
is more suitable than that of Siglec-H to selectively drive gene
expression in pDCs.
The effectiveness of the BDCA2-DTR Tg mouse model in
evaluating antiviral pDC functions was confirmed by our results
in the MCMV and VSV infections. We demonstrated that pDCs
are essential for the production of IFN-I only during the initial
stages of MCMV infection, which is in agreement with a study
by Delale et al. (2005). Additionally, we found that the impact
of pDC depletion on anti-MCMV responses is highly dependent
on initial viral dose, demonstrating that the antiviral capacity of
pDCs is limited. Because defects in IFN-I or MyD88 signaling
(Dalod et al., 2002, 2003; Delale et al., 2005; Krug et al., 2004a;
Steinberg et al., 2009; Zucchini et al., 2008) have more profound
impacts on anti-MCMV control than does pDC depletion, we
conclude that pDCs account only in part for the antiviral
responses mediated by IFN-I and MyD88 signaling and other
cells must be involved. CD11b+ DCs are also capable of
producing IFN-I and activating NK cells in a TLR-independent
manner after infection with MCMV (Andoniou et al., 2005). In
addition, both TLR3 and TLR2 pathways, which are not oper-
ating in pDCs, have been implicated in the secretion of IFN-Immunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc. 961
Figure 6. pDCs Enhance Accumulation of Ag-Specific CD8+ T Cells during VSV-OVA Infection
Purified CD8+ T cells from OT-I TCR Tg mice were CFSE labeled and adoptively transferred into BDCA2-DTR Tg mice. Mice were injected the following day with
PBS or DT, then infected i.v. with VSV-OVA (5 3 105 pfu) 24 hr later. Splenocytes isolated 66 hr p.i. were stained with anti-CD8 and -Va2 then analyzed by flow
cytometry. Data are from two experiments (mean ± SEM, n = 8).
(A) Dot plots show the frequencies of CFSE+ cells among CD8+Va2+ T cells. Histograms show the number of divisions based on CFSE dilution.
(B) Frequencies and absolute numbers of CFSE+CD8+Va2+ T cells. p value, unpaired, two-tailed Student’s t test.
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et al., 2006; Tabeta et al., 2004).
Although in the MCMV model pDCs efficiently contained viral
replication at low-to-intermediate viral loads but were insufficient
at restraining high viral loads, we must emphasize that most
natural infections in vivo occur by transmission of low numbers
of virions. Therefore, pDCs might play a critical role in containing
naturally spreading viral infections in physiological settings.
Furthermore, the inability of pDCs to augment antiviral
responses when higher MCMV doses are administered may be
due to their limited numbers in infected organs, such as spleen,
liver, and salivary glands. However, pDCsmay be able to control
higher viral loads during human infections such as varicella
zoster virus, hepatitis C virus, andmolluscum contagiosum virus,
which cause considerable accumulation of pDCs at sites of
infection (Sozzani et al., 2010).962 Immunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc.Previous studies have shown that pDCs activate NK cells, sug-
gesting that pDCs control viral spreading and replication indi-
rectly through NK cell-mediated killing of MCMV-infected cells.
In our study we evaluated the impact of pDC depletion on the
control of Dm157 MCMV, which escapes surveillance by
Ly49H+ NK cells (Lanier, 2008), and found that pDCs contribute
to the control of MCMV independently of Ly49H+ NK cells. Thus,
IFN-I released by pDCs controls MCMV replication directly by
inducing an antiviral state in other cells. As previously reported,
we confirmed that pDCs also induce NK cell activation, but
only during the early nonspecific phase of the NK cell response.
In contrast, pDCs were not required for activation of MCMV-
specific Ly49H+ NK cells, which in fact were more frequent in
pDC-depleted mice. This expansion of Ly49H+ cells is most
probably a consequence of increased viral titers and thus may
compensate for the lack of pDCs and their ability to control viral
Figure 7. Recruitment and Survival of Ag-Specific CD8+ T Cells during VSV-OVA Infection
(A) Serum concentrations of CCL4 in VSV-OVA-infected mice 24 hr p.i. Data are from three experiments.
(B) Purified CD8+ T cells from OT-I TCR Tg mice were CFSE labeled and adoptively transferred into BDCA2-DTR Tg mice. Mice were depleted and infected as
described in Figure 6. Splenocytes isolated at 6 or 22 hr p.i. were stained with anti-Va2 then analyzed by flow cytometry. Dot plots show the frequencies of CFSE+
cells among Va2+ cells. Data are representative of three to eight mice per group.
(C) Mice were injected with 2 3 106 CFSE-labeled CD8+ T cells from OT-I mice then infected in the footpad with VSV or VSV-OVA (1 3 106 pfu) 24 hr later.
Controlateral (CLN) and draining (DLN) lymph nodes were stained with anti-Va2 and analyzed by flow cytometry at 9 or 25 hr p.i. Data are representative of
three mice per group.
(D) Mice were injected with CFSE- or eFluor 670-labeled OT-I cells, then depleted or not and infected as described in Figure 6. Splenocytes were stained with
anti-CD8, anti-Va2, and Annexin V or CaspACE FITC-VAD-FMK 45 or 66 hr p.i. Bar graphs show the frequencies of OT-I cells among CD8+Va2+ cells (top) and
frequencies of apoptotic OT-I cells (bottom). Data are from two experiments (mean ± SEM, n = 4–8).
p value, unpaired, two-tailed Student’s t test.
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preferential expansion of Ly49H+ cells (Geurs et al., 2009).
pDC depletion resulted in an increased frequency of IFN-g-
producing NK cells and NKT cells in the spleen and liver, as
well as increased serum concentrations of IL-12p70 and produc-Ition of IL-12 by classical DCs. Previous studies in interferon
alpha receptor (IFNAR) gene-targeted mice and mice depleted
of pDCs with antibodies have demonstrated that IFN-I signaling
in classical DCs reduces IL-12 production during MCMV
infection (Dalod et al., 2002, 2003). Our data corroboratemmunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc. 963
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IFN-I limits IL-12 production by DCs and consequently IFN-g
production by NK cells and NKT cells. However, the impact of
pDC depletion on systemic IL-12 was not as strong as that
induced by blockade of IFN-I signaling, indicating that pDCs
are only one of the sources of IFN-I that contribute to the control
of the IL-12-IFN-g axis.
Infection of BDCA2-DTR mice with VSV indicated a role for
pDCs in the very early production of IFN-I and control
of viral burden. Moreover, pDCs promoted the accumulation of
Ag-specific CD8+ T cells, unveiling an important function of
pDCs in adaptive immune responses. This pDC function may
explain the delayed accumulation of T cells in the bronchoalveo-
lar space of Ikzf1L/L mice infected with influenza (Wolf et al.,
2009) and the defective CTL responses against HSV-1 infection
in pDC-depleted mice (Yoneyama et al., 2005). We explored
several mechanisms by which pDCsmay promote CTL accumu-
lation. We noticed that pDC depletion resulted in a significant
reduction in serum concentrations of CCL4, which attracts
CTLs to priming sites. However, pDC depletion had no clear
impact on the recruitment of adoptively transferred Ag-specific
CTLs. Although pDCs have been implicated in Ag presentation
in several models (Villadangos and Young, 2008), pDCs did not
present Ag in VSV-OVA infection nor increase the Ag-presenting
capacity of classical DCs. Instead we found that pDCs promoted
the survival of Ag-specific CTLs. Because pDCs limit viral repli-
cation early in VSV-OVA infection, CTL survival may be explained
by reduced activation-induced apoptosis. Additionally, pDCs
may promote CTL survival through soluble factors such as
IFN-I (Kolumam et al., 2005; Marrack and Kappler, 2004).
Not surprisingly, the defect of CTL accumulation in pDC-
depleted mice infected with VSV-OVA had no obvious impact
on viral loads in the brain at later time points (data not shown),
because VSV clearance is mainly dependent on Ab responses
(Steinhoff et al., 1995), which did not vary between control and
pDC-depleted mice (data not shown). However, pDC-mediated
accumulation of CTLs may be essential in the control of other
experimental infections, such as murine hepatitis virus (MHV),
herpes simplex virus 2 (HSV-2), and respiratory syncytial virus
(RSV), in which pDC depletion impairs host antiviral responses
(Cervantes-Barragan et al., 2007; Smit et al., 2006; Thompson
and Iwasaki, 2008; Wang et al., 2006). In conclusion, analysis
of MCMV and VSV infections in our newly generated BDCA2-
DTR Tg mice demonstrates that pDCs provide an early and
transient source of IFN-I that partially controls viral replication.
This pDC-mediated control of viral burden impacts the accrual
of virus-specific NK cells or CD8+ T cells in a virus-dependent
manner.EXPERIMENTAL PROCEDURES
Mice and Treatments
All animal studies were approved by theWashington University Animal Studies
Committee. BDCA2-DTR Tg and SiglecH-eGFP gene-targeted mice were
maintained as heterozygotes and used at 7–12 weeks of age. Diphtheria toxin
(DT, Sigma-Aldrich) was injected intraperitoneally (i.p.) at 100–120 ng/mouse.
pDCs were depleted on days 1, 1, and 3 in virus-infected mice. Mice were
administered PBS or DT only on day 1 in adoptive transfer experiments
with VSV-OVA. OT-I and OT-II TCR Tg mice were used between 8 and
12 weeks of age.964 Immunity 33, 955–966, December 22, 2010 ª2010 Elsevier Inc.Viruses and Infections
Smith strains MCMV and AT1.5 (Dm157) were generous gifts of W. Yokoyama
and A. French (Washington University, St. Louis, MO), respectively. MCMV
tissue culture (TC) stocks were prepared by propagation in BALB/c NIH3T12
fibroblasts (3T12, ATCC). Salivary gland (SG) MCMV stocks were prepared
from BALB/c mice that were infected i.p. with 13 106 pfu of TC stock. Indiana
strain VSV-OVA and VSV were provided by L. Lefranc¸ois (University of
Connecticut, Farmington, CT) and D. Lenschow (Washington University),
respectively. Mice were infected i.p. with different doses (specified in figures
and text) of MCMV SG stocks. VSV-OVA was administered intravenously
(i.v.) at doses of 5 3 105 or 5 3 106 pfu/mouse. For footpad (f.p.) infections,
mice were injected with 1 3 106 pfu of VSV or VSV-OVA.
Virus Plaque Assays
MCMV and VSV titers were determined by standard plaque assays. A detailed
description of methods can be found in the Supplemental Information.
Cell Preparations
Spleens were minced and digested for 45 min at 37C in RPMI 1640 with
collagenase D (Sigma-Aldrich). Single-cell suspensions of spleens and lymph
nodes were prepared by passage through nylon mesh cell strainers (BD
Biosciences). Red blood cells (RBC) were lysed with RBC lysis buffer
(Sigma-Aldrich). Liver cells were isolated by digesting minced lobes for 1 hr
at 37C in RPMI 1640 containing DNase I (Sigma-Aldrich) and collagenase
D. Leukocytes were isolated over a 40%–70% Percoll gradient. Whole blood
was collected by cardiac puncture and bone marrow cells were harvested
from tibias and femurs.
Antibodies and Flow Cytometry
A detailed list of antibodies, reagents, and staining methods can be found in
the Supplemental Information. All flow cytometry was conducted on a dual
laser FACSCalibur flow cytometer (BD Biosciences) and analyzed with FlowJo
software (Tree Star, Inc.).
ELISA and Cytometric Bead Array
Serum samples from infected mice were collected at various time points p.i.
IFN-a concentrations were determined by ELISA (PBL Interferon Source).
IL-12p70 and IFN-g were measured by flow cytometry with the Mouse Inflam-
mation CBA kit (BD Biosciences) and CCL3 and CCL4 were quantified by flow
cytometry with Mouse CBA flex sets (BD Biosciences).
Cell Lines and Tissue Culture
EL4 and RMA-S cells were grown in complete RPMI: RPMI 1640 with 10%
bovine calf serum (BCS), 1% glutamax, 1% nonessential amino acids, 1%
sodium pyruvate, and 1% kanamycin sulfate (GIBCO-Invitrogen). 3T12 and
Vero cells were cultured in complete DMEM: high-glucose DMEM, 10%
BCS, 1% glutamax, 1% HEPES, and 1% penicillin plus streptomycin
(GIBCO-Invitrogen). Primary cells were cultured in complete RPMI with 10%
fetal calf serum (FCS, Hyclone).
Cytotoxicity Assays
For NK cell cytotoxicity assays, splenocytes from MCMV-infected mice were
resuspended in complete RPMI and serially diluted in 96-well round
bottom plates. RMA-S cells were labeled with 1 mCi/ml 51Cr for 2 hr then incu-
bated with effector cells at 37C for 4 hr. 51Cr release in supernatants was
measured with a g-counter. For Ag-specific lysis assays, splenocytes from
mice infected with VSV-OVA were resuspended in complete RPMI and serially
diluted. EL4 cells were pulsed or not pulsed with H-2Kb OVA257-264 peptide
(SIINFEKL, 10 ng/ml) and labeled with 51Cr as described above.
T Cell Restimulation Assays
Splenocytes from VSV-OVA-infected mice were incubated at 37C in
complete RPMI alone or with PMA+Ionomycin or SIINFEKL (10 mg/ml) in the
presence of brefeldin A. After 6 hr cells were intracellularly stained for IFN-g.
Antigen Presentation Assays
DCs were enriched from VSV-OVA-infected mice 24 hr p.i. by positive selec-
tion with anti-CD11c beads (Miltenyi Biotec). DCs were incubated with CD8+
Immunity
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and IFN-g was measured in culture supernatants.
T Cell Purification, CFSE Labeling, and Adoptive Transfer
Naive CD8+ or CD4+ T cells were obtained from OT-I or OT-II TCR Tg mice by
negative selection with CD8+ or CD4+ T cell isolation kits (Miltenyi Biotec)
according to the manufacturer’s instructions. Purity was greater than 90%
as determined by flow cytometry. Purified CD8+ T cells were labeled for
10 min at room temperature with 1–5 mM CFSE (Invitrogen-Molecular Probes)
or cell proliferation dye eFluor 670 (eBioscience) and 1 3 106 labeled CD8+
T cells were injected i.v. into DTR mice. For f.p. infections, 2 3 106 CFSE-
labeled CD8+ T cells were injected i.v. 24 hr before VSV or VSV-OVA.
Apoptosis Assessment
Spleens were harvested from VSV-OVA-infected mice and single-cell suspen-
sions were prepared as described above. After surface staining, cells were
incubated with Annexin V (BD Biosciences) or CaspACE FITC-VAD-FMK
(Promega) as recommended by the manufacturers.
Statistical Analysis
The statistical significance of differences in mean values was analyzed with
unpaired, two-tailed Student’s t test. p values less than 0.05 were considered
statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/
j.immuni.2010.11.020.
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